VALNEVA (EPA:VLA) | WebDisclosure

BRIEF

published on 08/18/2025 at 07:05, 7 months 4 days ago

Le Vaccin IXCHIQ® de Valneva Autorisé au Canada pour les 12 Ans et Plus

Valneva Santé Canada Autorisation Vaccin Chikungunya
PRESS RELEASE

published on 08/18/2025 at 07:00, 7 months 4 days ago

Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older
Valneva's Chikungunya Vaccine IXCHIQ® authorized in Canada for individuals aged 12 and older. Health Canada grants marketing authorization for disease prevention

Canada Health Valneva Vaccine Chikungunya
PRESS RELEASE

published on 08/18/2025 at 07:00, 7 months 4 days ago

Le vaccin IXCHIQ® de Valneva contre le chikungunya désormais autorisé au Canada pour les personnes âgées de 12 ans et plus
Valneva obtient l'autorisation de Santé Canada pour son vaccin IXCHIQ® contre le chikungunya chez les + de 12 ans. Le vaccin est approuvé en Europe pour les adolescents. Les données de phase 3 montrent une réponse immunitaire durable

Valneva Autorisation Vaccin Chikungunya IXCHIQ®
BRIEF

published on 08/12/2025 at 07:05, 7 months 10 days ago

Valneva's Half-Year 2025 Financial Report: Growth and Strategic Moves

Financial Results Strategic Partnerships Revenue Growth Cash Management Regulatory Updates
BRIEF

published on 08/12/2025 at 07:05, 7 months 10 days ago

Rapport financier semestriel 2025 de Valneva : croissance et évolutions stratégiques

Résultats Financiers Partenariats Stratégiques Croissance Des Revenus Gestion De Trésorerie Mises À Jour Réglementaires
PRESS RELEASE

published on 08/12/2025 at 07:00, 7 months 10 days ago

VALNEVA : Rapport Semestriel 2025
PRESS RELEASE

published on 08/12/2025 at 07:00, 7 months 10 days ago

Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités
Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités. Chiffre d’affaires en hausse, trésorerie solide et perspectives confirmées. Détails disponibles sur le site de la société

Résultats Financiers Perspectives Valneva Vaccins Premier Semestre 2025
PRESS RELEASE

published on 08/12/2025 at 07:00, 7 months 10 days ago

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Valneva SE reports €97.6 million revenues in H1 2025, confirms 2025 financial outlook. Highlights financial results, R&D progress, and commercial updates

Revenues Financial Results Valneva SE R&D Progress 2025 Outlook Commercial Updates
BRIEF

published on 08/07/2025 at 07:22, 7 months 15 days ago

Valneva Obtains FDA Lift of Ban on IXCHIQ®

FDA Valneva Chikungunya IXCHIQ® Vaccine Elderly People
BRIEF

published on 08/07/2025 at 07:22, 7 months 15 days ago

Valneva obtient la levée de l'interdiction de la FDA pour IXCHIQ®

FDA Valneva Personnes Âgées Chikungunya Vaccin IXCHIQ®

Published on 03/23/2026 at 02:00, 1 hour 57 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 4 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 6 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 6 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 14 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

View all ACCESSWIRE

Published on 03/23/2026 at 03:35, 22 minutes ago

Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 18:22, 9 hours 35 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 15 hours 34 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 5 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 6 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications

View all EQS

Published on 03/20/2026 at 19:00, 2 days 8 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 8 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 9 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 9 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 10 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News